Vermillion this week appointed Bruce Huebner to its board of directors.
Currently Huebner is managing director at the healthcare consulting firm LynxCom Partners. Previously he was president and CEO of microarray company Nanogen, and before that he was executive vice president and chief operating officer of Gen-Probe.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
